Assessment of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis: A tissue doppler echocardiographic analysis

Echocardiography

Volumn 26, Issue 4, 2009, Pages 397-402

  Pattoneri, Paolo ^a   Sozzi, Fabiola ^b   Pelà, Giovanna ^b   Montanari, Enrico ^c   Moruzzi, Paolo ^d   Borghetti, Alberico ^d   Cappellini, Maria Domenica ^e  

^a UNIVERSITY OF PARMA   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c Hospital of Fidenza   (Italy)

^d Hospital of Fidenza/San Secondo   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Cardiotoxicity; Mitoxantrone; Multiple sclerosis; Tissue Doppler echocardiography

Indexed keywords

MITOXANTRONE;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOTOXICITY; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLIC BLOOD PRESSURE; FEMALE; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HEART RATE; HUMAN; MALE; MITRAL VALVE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING;

ADULT; ECHOCARDIOGRAPHY, DOPPLER; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOXANTRONE; MULTIPLE SCLEROSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 63849299043     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2008.00812.x     Document Type: Article

References (28)

1. Edan G, Miller D, Clanet M, et al : Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: A randomized multicentre study of active disease using MRI and clinical criteria. J Neurol Neurosurg Psychiatry 1997 62 : 112 118.
2. Hartung HP, Gonsette R, Konig N, et al : Mitoxantrone in progressive multiple sclerosis: A placebo-controlled, duble-blind, randomised, multicentre trial. Lancet 2002 360 : 2018 2025.
3. Praga C, Beretta G, Vigo PL, et al : Adriamycin cardiotoxicity: A survey of 1273 patients. Cancer Treat Rep 1979 63 : 827 834.
4. Edan G, Brochet B, Clanet M, et al : Safety profile of mitoxantrone in a cohort of 800 multiple sclerosis patients. Mult Scler 2001 7 : S14.
5. Mauch E, Kornhuber HH, Krapf H, et al : Treatment of multiple sclerosis with mitoxantrone. Eur Arch Psychiatry Clin Neurosci 1992 242 : 96 102.
6. Hartung HP, Gonsette R, Morrissey SP, et al : Mitoxantrone. In Rudick RA, Goodkin DE (eds Multiple Sclerosis Therapeutics. London : Martin Dunitz, 1999, pp. 335 348.
7. De Castro S, Cartoni D, Millefiorini E, et al : Noninvasive assessment of mitoxantrone cardiotoxicity in relapsing remitting multiple sclerosis. J Clin Pharmacol 1995 35 : 627 632.
8. Strotmann JM, Spindler M, Weilbach FX, et al : Myocardial function in patients with multiple sclerosis treated with low-dose of mitoxantrone. Am J Cardiol 2002 89 : 1222 1225.
9. Sohn DW, Chai IH, Lee DJ, et al : Assessment of mitral annulus velocity by doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997 30 : 474 480.
10. Oki T, Tabata T, Yamada H, et al : Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation. Am J Cardiol 1997 79 : 921 928.
11. Nagueh SF, Middleton KJ, Kopelen HA, et al : Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997 30 : 1527 1533.
12. Gulati VK, Katz WE, Follansbee WP, et al : Mitral annular descent velocity by tissue Doppler echocardiography as an index of global left ventricular function. Am J Cardiol 1996 77 : 979 984.
13. Galiuto L, Ignone G, DeMaria AN : Contraction and relaxation velocities of the normal left ventricle using pulsed-wave tissue Doppler echocardiography. Am J Cardiol 1998 81 : 609 614.
14. Schiller NB, Shah PM, Crawford M, et al : Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989 2 : 358 368.
15. Devereux RB, Reichek N : Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 1977 55 : 613 618.
16. Pattoneri P, Pelà G, Sozzi F, et al : Impact of myocardial geometry on left ventricular performance in healthy black and white young adults. Echocardiography 2008 25 : 13 19.
17. Sohn DW, Chung WY, Chai IH, et al : Mitral annulus velocity in the noninvasive estimation of left ventricular peak dp/dt. Am J Cardiol 2001 87 : 933 6.
18. Neilan TG, Jassal DS, Perez-Sanz TM, et al : Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J 2006 27 : 1868 1875.
19. Noseworthy JH, Gold R, Hartung HP : Treatment of multiple sclerosis: Recent trials and future perspectives. Curr Opin Neurol 1999 12 : 179 193.
20. Millefiorini E, Gasperini C, Pozzilli C, et al : Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome. J Neurol 1997 244 : 153 159.
21. Aviles A, Arevila N, Diaz Maqueo JC, et al : Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults. Leuk Lymphoma 1993 11 : 275 279.
22. Ganz WI, Sridhar KS, Ganz SS, et al : Review of tests for monitoring doxorubicin-induced cardiomyopathy. Oncology 1996 53 : 461 470.
23. Prestor VV, Rakovec P, Kozelj M, et al : Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood. Pediatr Hematol Oncol 2000 17 : 527 540.
24. Suzuki J, Yanagisawa A, Shigeyama T, et al : Early detection of anthracycline-induced cardiotoxicity by radionuclide angiography. Angiology 1999 50 : 37 45.
25. Schmitt K, Tulzer G, Merl M, et al : Early detection of doxorubicin and daunorubicin cardiotoxicity by echocardiography: Diastolic versus systolic parameters. Eur J Pediatr 1995 154 : 201 204.
26. Pattoneri P, Pelà G, Montanari E, et al : Evaluation of the myocardial performance index for early detection of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis. Eur J Echocardiogr 2007 8 : 144 150.
27. Pelà G, Bruschi G, Cavatorta A, et al : Doppler tissue echocardiography: Myocardial wall motion velocities in essential hypertension. Eur J Echo 2001 2 : 108 117.
28. Pelà G, Tirabassi G, Pattoneri P, et al : Cardiac involvement in the Churg-Strauss syndrome. Am J Cardiol 2006 97 : 1519 1524.